{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T19:46:03Z","timestamp":1766087163394},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Immunological Methods"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.jim.2017.02.006","type":"journal-article","created":{"date-parts":[[2017,2,16]],"date-time":"2017-02-16T09:02:06Z","timestamp":1487235726000},"page":"36-46","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Flow cytometric-based protocols for assessing anti-MT-2 IgG1 reactivity: High-dimensional data handling to define predictors for clinical follow-up of Human T-cell Leukemia virus type-1 infection"],"prefix":"10.1016","volume":"444","author":[{"given":"Jordana Grazziela","family":"Coelho-dos-Reis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vanessa","family":"Peruhype-Magalh\u00e3es","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcelo Ant\u00f4nio","family":"Pascoal-Xavier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matheus","family":"de Souza Gomes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurence Rodrigues","family":"do Amaral","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ludmila Melo","family":"Cardoso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Jonathan-Gon\u00e7alves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c1gata Lopes","family":"Ribeiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana L\u00facia Borges","family":"Starling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jo\u00e3o Gabriel","family":"Ribas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Denise Utsch","family":"Gon\u00e7alves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna B\u00e1rbara","family":"de Freitas Carneiro-Proietti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andr\u00e9a","family":"Teixeira-Carvalho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olindo Assis","family":"Martins-Filho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jim.2017.02.006_bb0005","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.meegid.2016.08.020","article-title":"Analyses of HTLV-1 sequences suggest interaction between ORF-I mutations and HAM\/TSP outcome","volume":"45","author":"Barreto","year":"2016","journal-title":"Infect. Genet. Evol."},{"issue":"6","key":"10.1016\/j.jim.2017.02.006_bb0010","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1046\/j.1365-3083.2002.01087.x","article-title":"Phenotypic study of peripheral blood leucocytes in HTLV-I-infected individuals from Minas Gerais, Brazil","volume":"55","author":"Brito-Melo","year":"2002","journal-title":"Scand. J. Immunol."},{"issue":"6","key":"10.1016\/j.jim.2017.02.006_bb0015","first-page":"1105","article-title":"Establishing phenotypic features associated with morbidity in human T-cell lymphotropic virus type 1 infection","volume":"11","author":"Brito-Melo","year":"2004","journal-title":"Clin. Diagn. Lab. Immunol."},{"issue":"1","key":"10.1016\/j.jim.2017.02.006_bb0020","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1365-2249.2006.03252.x","article-title":"IL-10 produced by CD4+ and CD8+ T cells emerge as a putative immunoregulatory mechanism to counterbalance the monocyte-derived TNF-alpha and guarantee asymptomatic clinical status during chronic HTLV-I infection","volume":"147","author":"Brito-Melo","year":"2007","journal-title":"Clin. Exp. Immunol."},{"issue":"4","key":"10.1016\/j.jim.2017.02.006_bb0025","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s13365-014-0249-3","article-title":"Digital droplet PCR (ddPCR) for the precise quantification of human T-lymphotropic virus 1 proviral loads in peripheral blood and cerebrospinal fluid of HAM\/TSP patients and identification of viral mutations","volume":"20","author":"Brunetto","year":"2014","journal-title":"J. Neurovirol."},{"issue":"1","key":"10.1016\/j.jim.2017.02.006_bb0030","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1590\/S0037-86822007000100006","article-title":"Evaluation of the performance of immunological parameters as indicators for clinical progression of chronic HTLV-1 infection","volume":"40","author":"Coelho-dos-Reis","year":"2007","journal-title":"Rev. Soc. Bras. Med. Trop."},{"issue":"1\u20132","key":"10.1016\/j.jim.2017.02.006_bb0035","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.jviromet.2009.05.007","article-title":"Performance of IgG and IgG1 anti-HTLV-1 reactivity by an indirect immunofluorescence flow cytometric assay for the identification of persons infected with HTLV-1, asymptomatic carriers and patients with myelopathy","volume":"160","author":"Coelho-dos-Reis","year":"2009","journal-title":"J. Virol. Methods"},{"issue":"1\u20132","key":"10.1016\/j.jim.2017.02.006_bb0040","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jviromet.2011.03.019","article-title":"Evaluation of the effects of Quercetin and Kaempherol on the surface of MT-2 cells visualized by atomic force microscopy","volume":"174","author":"Coelho-Dos-Reis","year":"2011","journal-title":"J. Virol. Methods"},{"issue":"7(7)","key":"10.1016\/j.jim.2017.02.006_bb0045","doi-asserted-by":"crossref","first-page":"e2328","DOI":"10.1371\/journal.pntd.0002328","article-title":"Immunological profile of HTLV-1-infected patients associated with infectious or autoimmune dermatological disorders","volume":"25","author":"Coelho-dos-Reis","year":"2013","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"10","key":"10.1016\/j.jim.2017.02.006_bb0050","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1089\/aid.2006.22.931","article-title":"Proposal for diagnostic criteria of tropical spastic paraparesis\/HTLV-I-associated myelopathy (TSP\/HAM)","volume":"22","author":"De Castro-Costa","year":"2006","journal-title":"AIDS Res. Hum. Retrovir."},{"issue":"4","key":"10.1016\/j.jim.2017.02.006_bb0055","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1128\/JCM.44.4.1550-1554.2006","article-title":"Seroprevalence and molecular epidemiology of human T-cell leukemia virus type 1 (HTLV-1) and HTLV-2 in blood donors from Dakar, Senegal","volume":"44","author":"Diop","year":"2006","journal-title":"J. Clin. Microbiol."},{"issue":"4","key":"10.1016\/j.jim.2017.02.006_bb0060","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1002\/jmv.23227","article-title":"Monitoring the HTLV-1 proviral load in the peripheral blood of asymptomatic carriers and patients with HTLV-associated myelopathy\/tropical spastic paraparesis from a Brazilian cohort: ROC curve analysis to establish the threshold for risk disease","volume":"84","author":"Furtado Mdos","year":"2012","journal-title":"J. Med. Virol."},{"issue":"26","key":"10.1016\/j.jim.2017.02.006_bb0065","doi-asserted-by":"crossref","first-page":"3029","DOI":"10.1182\/blood-2016-09-739433","article-title":"Screening transplant donors for HTLV-1 and -2","volume":"128","author":"Gallo","year":"2016","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.jim.2017.02.006_bb0070","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1097\/00126334-200403010-00012","article-title":"Seroepidemiology of HTLV-I\/II in Argentina: an overview","volume":"35","author":"Gastaldello","year":"2004","journal-title":"J. Acquir. Immune Defic. Syndr."},{"issue":"3","key":"10.1016\/j.jim.2017.02.006_bb0075","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1128\/CMR.00063-09","article-title":"Epidemiology, treatment, and prevention of human T-cell leukemia virus type 1-associated diseases","volume":"23","author":"Gon\u00e7alves","year":"2010","journal-title":"Clin. Microbiol. Rev."},{"issue":"9","key":"10.1016\/j.jim.2017.02.006_bb0080","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1001\/jama.1994.03510330081039","article-title":"Users' guides to the medical literature. III. How to use an article about a diagnostic test. B. What are the results and will they help me in caring for my patients? The evidence-based medicine working group","volume":"271","author":"Jaeschke","year":"1994","journal-title":"JAMA"},{"issue":"4946","key":"10.1016\/j.jim.2017.02.006_bb0085","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1126\/science.2309119","article-title":"HTLV-I trans-activator protein, tax, is a trans-repressor of the human beta-polymerase gene","volume":"247","author":"Jeang","year":"1990","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.jim.2017.02.006_bb0090","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1089\/aid.2014.0153","article-title":"Electrophysiological analysis shows dizziness as the first symptom in human T cell lymphotropic virus type-associated myelopathy\/tropical spastic paraparesis","volume":"31","author":"Labanca","year":"2015","journal-title":"AIDS Res. Hum. Retrovir."},{"issue":"5","key":"10.1016\/j.jim.2017.02.006_bb0095","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/nm0502-509","article-title":"Autoimmunity due to molecular mimicry as a cause of neurological disease","volume":"8","author":"Levin","year":"2002","journal-title":"Nat. Med."},{"issue":"6","key":"10.1016\/j.jim.2017.02.006_bb0100","first-page":"978","article-title":"A T-cell line derived from normal human cord leukocytes by co-culturing with human leukemic T-cells","volume":"72","author":"Miyoshi","year":"1981","journal-title":"Gann"},{"key":"10.1016\/j.jim.2017.02.006_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/S1473-3099(16)30322-X","article-title":"Measuring incidence of HTLV-1: the other human retrovirus","author":"Mollenkopf","year":"2016","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.jim.2017.02.006_bb0110","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2016-215243","article-title":"HTLV-1-associated myelopathy in a solid organ transplant recipient","author":"Montesdeoca Andrade","year":"2016","journal-title":"BMJ Case Rep."},{"issue":"2","key":"10.1016\/j.jim.2017.02.006_bb0115","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1006\/viro.1998.9578","article-title":"Two types of HTLV-1 particles are released from MT-2 cells","volume":"255","author":"Morozov","year":"1999","journal-title":"Virology"},{"issue":"10","key":"10.1016\/j.jim.2017.02.006_bb0120","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1089\/aid.2013.0015","article-title":"Molecular study of HBZ and gp21 human T cell leukemia virus type 1 proteins isolated from different clinical profile infected individuals","volume":"29","author":"Mota-Miranda","year":"2013","journal-title":"AIDS Res. Hum. Retrovir."},{"issue":"12","key":"10.1016\/j.jim.2017.02.006_bb0125","first-page":"1200","article-title":"The recent advances of HAM\/TSP research","volume":"39","author":"Osame","year":"1999","journal-title":"Rinsho Shinkeigaku"},{"issue":"5","key":"10.1016\/j.jim.2017.02.006_bb0130","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1080\/13550280260422668","article-title":"Pathological mechanisms of human T-cell lymphotropic virus type I-associated myelopathy (HAM\/TSP)","volume":"8","author":"Osame","year":"2002","journal-title":"J. Neurovirol."},{"issue":"8488","key":"10.1016\/j.jim.2017.02.006_bb0135","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/S0140-6736(86)91298-5","article-title":"HTLV-I associated myelopathy, a new clinical entity","volume":"1","author":"Osame","year":"1986","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.jim.2017.02.006_bb0140","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/j.1365-2249.2006.03171.x","volume":"146","author":"Peruhype-Magalh\u00e3es","year":"2006","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jim.2017.02.006_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/S1473-3099(16)30252-3","article-title":"Incidence of human T-lymphotropic virus 1 infection in adolescent and adult blood donors in Japan: a nationwide retrospective cohort analysis","author":"Satake","year":"2016","journal-title":"Lancet Infect. Dis."},{"issue":"1","key":"10.1016\/j.jim.2017.02.006_bb0150","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.actatropica.2012.09.012","article-title":"Proviral load and the balance of serum cytokines in HTLV-1-asymptomatic infection and in HTLV-1-associated myelopathy\/tropical spastic paraparesis (HAM\/TSP)","volume":"125","author":"Starling","year":"2013","journal-title":"Acta Trop."},{"issue":"6\u20137","key":"10.1016\/j.jim.2017.02.006_bb0155","doi-asserted-by":"crossref","first-page":"502","DOI":"10.3109\/1354750X.2015.1094141","article-title":"Immunological signature of the different clinical stages of the HTLV-1 infection: establishing serum biomarkers for HTLV-1-associated disease morbidity","volume":"20","author":"Starling","year":"2015","journal-title":"Biomarkers"},{"issue":"4857","key":"10.1016\/j.jim.2017.02.006_bb0160","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1126\/science.3287615","article-title":"Measuring the accuracy of diagnostic systems","volume":"240","author":"Swets","year":"1988","journal-title":"Science"},{"issue":"8","key":"10.1016\/j.jim.2017.02.006_bb0165","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1111\/trf.13678","article-title":"Motivations for donating and attitudes toward screening policies in US blood donors with viral infection","volume":"56","author":"Vahidnia","year":"2016","journal-title":"Transfusion"},{"key":"10.1016\/j.jim.2017.02.006_bb0170","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.antiviral.2016.10.015","article-title":"Reducing the global burden of HTLV-1 infection: an agenda for research and action","volume":"137","author":"Willems","year":"2017","journal-title":"Antivir. Res."}],"container-title":["Journal of Immunological Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022175916303404?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022175916303404?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,23]],"date-time":"2022-06-23T18:52:35Z","timestamp":1656010355000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022175916303404"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":34,"alternative-id":["S0022175916303404"],"URL":"https:\/\/doi.org\/10.1016\/j.jim.2017.02.006","relation":{},"ISSN":["0022-1759"],"issn-type":[{"type":"print","value":"0022-1759"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Flow cytometric-based protocols for assessing anti-MT-2 IgG1 reactivity: High-dimensional data handling to define predictors for clinical follow-up of Human T-cell Leukemia virus type-1 infection","name":"articletitle","label":"Article Title"},{"value":"Journal of Immunological Methods","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jim.2017.02.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}